Data is not available at this time.
Medical Net, Inc. operates as a specialized digital platform provider in Japan, focusing on medical, dental, and lifestyle information services. The company generates revenue through a combination of advertising, clinic management support, and enterprise marketing services tailored to the healthcare and beauty sectors. Its core offerings include dental implant and orthodontic treatment portals, aesthetic dental resources, and comprehensive medical care directories, positioning it as a niche leader in online healthcare information. Medical Net differentiates itself by aggregating specialized content, such as cosmetic surgery rankings, beauty salon searches, and pet examination resources, catering to both consumers and businesses. The company’s dual revenue model—combining B2C digital advertising with B2B marketing support—allows it to monetize its extensive user base while serving clinics and beauty providers. Despite operating in a competitive digital landscape, Medical Net maintains relevance through localized, high-intent traffic and deep sector expertise, though its market share remains modest compared to broader internet content players.
Medical Net reported revenue of ¥5.25 billion (JPY) for FY 2024, with net income sharply declining to ¥5.96 million, reflecting thin margins in its advertising-driven model. Operating cash flow of ¥119.6 million suggests modest operational efficiency, though capital expenditures were minimal at ¥-32.8 million, indicating limited reinvestment in growth. The company’s profitability challenges stem from high traffic acquisition costs and competitive pressures in digital healthcare advertising.
Diluted EPS of ¥0.66 underscores weak earnings power, likely due to revenue concentration in low-margin ad services and marketing support. The company’s capital efficiency is constrained by its debt-heavy structure, with total debt of ¥1.03 billion outweighing operating cash flow generation. However, its ¥1.53 billion cash reserve provides liquidity to service obligations.
Medical Net’s balance sheet shows liquidity with ¥1.53 billion in cash against ¥1.03 billion in total debt, yielding a net cash position. However, the debt load remains significant relative to its market cap of ¥2.87 billion, suggesting moderate leverage. The absence of aggressive capex signals a focus on maintaining financial stability over expansion.
Growth appears stagnant, with minimal net income and flat operational metrics. The company pays a dividend of ¥3 per share, implying a yield of ~0.1% at current prices, likely aimed at retaining investor interest despite limited growth prospects. Its focus on niche healthcare verticals limits scalability without diversification.
Trading at a market cap of ¥2.87 billion, the company’s valuation reflects its niche position and subdued earnings. A beta of 0.487 indicates lower volatility than the broader market, aligning with its stable but low-growth profile. Investors likely price in limited upside without operational improvements.
Medical Net’s deep specialization in Japanese healthcare digital services offers defensibility, but reliance on advertising revenue exposes it to sector cyclicality. Strategic partnerships or vertical integration could enhance margins, though current execution lacks differentiation. The outlook remains neutral, hinging on monetization improvements or market consolidation.
Company description, financials from disclosed filings (FY 2024), market data from JPX.
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |